Asklepios BioPharmaceutical
Christian Rommel became EVP, Global Head of Research & Development and a member of the executive committee of Bayer Pharmaceuticals in February 2021. He joined Bayer from Roche, where he was most recently Senior VP, Global Head of Oncology, Pharma Research and Early Development (pRED). Rommel also served at Amgen as Vice President of External Research and Development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Asklepios BioPharmaceutical
1 followers
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.